NM_002890.3:c.2690+808G>A

Variant names:

• chr5-87381403-G-A
• rs3827607
• NM_002890.3:c.2690+808G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_002890.3(RASA1):​c.2690+808G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.419 in 151,998 control chromosomes in the GnomAD database, including 13,365 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.42 (13365 hom., cov: 32)
• Consequence: RASA1 NM_002890.3 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.335
• Publications: 7 publications found

Genes affected

RASA1 (HGNC:9871): (RAS p21 protein activator 1) The protein encoded by this gene is located in the cytoplasm and is part of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. Mutations leading to changes in the binding sites of either protein are associated with basal cell carcinomas. Mutations also have been associated with hereditary capillary malformations (CM) with or without arteriovenous malformations (AVM) and Parkes Weber syndrome. Alternative splicing results in two isoforms where the shorter isoform, lacking the N-terminal hydrophobic region but retaining the same activity, appears to be abundantly expressed in placental but not adult tissues. [provided by RefSeq, May 2012]

CCNH (HGNC:1594): (cyclin H) The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with CDK7 kinase and ring finger protein MAT1. The kinase complex is able to phosphorylate CDK2 and CDC2 kinases, thus functions as a CDK-activating kinase (CAK). This cyclin and its kinase partner are components of TFIIH, as well as RNA polymerase II protein complexes. They participate in two different transcriptional regulation processes, suggesting an important link between basal transcription control and the cell cycle machinery. A pseudogene of this gene is found on chromosome 4. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Nov 2010]

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.94).
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.468 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002890.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	RASA1	NM_002890.3	MANE Select	c.2690+808G>A		intron	N/A	NP_002881.1
	RASA1	NM_022650.3		c.2159+808G>A		intron	N/A	NP_072179.1
	CCNH	NM_001364075.2		c.933+13641C>T		intron	N/A	NP_001351004.1

Ensembl Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	RASA1	ENST00000274376.11	TSL:1 MANE Select	c.2690+808G>A		intron	N/A	ENSP00000274376.6
	RASA1	ENST00000456692.6	TSL:1	c.2159+808G>A		intron	N/A	ENSP00000411221.2
	RASA1	ENST00000515800.6	TSL:1	n.*1215+808G>A		intron	N/A	ENSP00000423395.2

Frequencies

GnomAD3 genomes AF: 0.419 AC: 63673 AN: 151880 Hom.: 13344 Cov.: 32

Gnomad AFR AF: 0.441

Gnomad AMI AF: 0.455

Gnomad AMR AF: 0.372

Gnomad ASJ AF: 0.415

Gnomad EAS AF: 0.485

Gnomad SAS AF: 0.454

Gnomad FIN AF: 0.424

Gnomad MID AF: 0.497

Gnomad NFE AF: 0.407

Gnomad OTH AF: 0.431

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.419 AC: 63731 AN: 151998 Hom.: 13365 Cov.: 32 AF XY: 0.421 AC XY: 31308 AN XY: 74294

African (AFR) AF: 0.442 AC: 18301 AN: 41446

American (AMR) AF: 0.371 AC: 5675 AN: 15278

Ashkenazi Jewish (ASJ) AF: 0.415 AC: 1439 AN: 3464

East Asian (EAS) AF: 0.484 AC: 2506 AN: 5176

South Asian (SAS) AF: 0.455 AC: 2193 AN: 4820

European-Finnish (FIN) AF: 0.424 AC: 4468 AN: 10550

Middle Eastern (MID) AF: 0.486 AC: 143 AN: 294

European-Non Finnish (NFE) AF: 0.407 AC: 27682 AN: 67956

Other (OTH) AF: 0.432 AC: 909 AN: 2102

Alfa AF: 0.415 Hom.: 10223

Bravo AF: 0.421

Asia WGS AF: 0.455 AC: 1584 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.94
CADD	Benign	4.4
DANN	Benign	0.68
PhyloP100		-0.34
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs3827607; hg19: chr5-86677220; COSMIC: COSV57193313; COSMIC: COSV57193313;